US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices....